2021 Investor Day slide image

2021 Investor Day

Compounding impact from patient adherence Mask growth paradigm Growth Installed base New patients Automated ReSupply New products Increased long- term adherence Time Digital innovation has powered mask growth Long-term patient adherence results in increased recurring revenue Mask growth has improved over time: FY12-16 CAGR of 8% FY17-21 CAGR of 10% Focused on driving increased mask growth to drive recurring revenue © 2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 83
View entire presentation